電気生理学の世界市場（2025年～2033年）

世界の電気生理学の市場規模は、2023年に82億4,000万米ドルに達し、2033年には230億米ドルに達すると予測され、予測期間2025年～2033年にはCAGR10.7%で成長する見通しです。

電気生理学は、異常な心臓リズムを診断・治療するために心臓の電気的活動を分析する心臓病学分野です。医療提供者は心臓カテーテルとコンピュータを使用して心電図（EKG）トレースを作成し、心臓内部からの電気的測定を行います。この研究は、通常一定のルートをたどる心拍信号の問題を特定するのに役立ちます。心臓内部に設置されたセンサーは、外部電極よりも多くの情報を提供します。

市場力学：

促進要因と抑制要因

技術進歩の高まり

世界の電気生理学市場は、診断・治療ツールの技術進歩により成長しています。高度なマッピングシステム、カテーテル設計、ロボット支援処置により、心臓不整脈の診断と治療効率が向上しています。人工知能と機械学習はデータ分析に革命をもたらし、個別化された治療計画を可能にし、処置リスクを低減しています。ワイヤレスで小型化された機器とリアルタイムのモニタリング機能の開発により、電気生理学適応症が拡大し、患者の予後が改善し、低侵襲処置に対する需要の高まりに対応しています。

例えば、2024年1月、GE HealthCareは最先端の電気生理学ツールであるPrucka 3 with CardioLab EP Recordingシステムを発表し、臨床医による心臓不整脈の診断と治療を支援しています。20年以上にわたる電気生理学の専門知識に基づいて構築されたこのシステムは、心臓不整脈の診断と治療において、正確、効率的、高度な分析のためのマッピング技術の包括的なエコシステムを提供します。

熟練した専門家の不足

世界の電気生理学市場は、専門知識を必要とする処置の複雑さにより、熟練した専門家の著しい不足に直面しています。特に開発途上地域では、カテーテルを用いたアブレーションや電気生理学マッピングシステムのような先進技術の普及の妨げとなる可能性があります。このような技術不足は、既存の専門家への負担を増大させ、待ち時間を長くし、患者の予後を悪化させる可能性があります。このスキルギャップに対処することは、市場の成長と先端技術の効率的な利用にとって極めて重要です。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • 技術進歩の高まり
  • 抑制要因
    • 熟練した専門家の不足
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析

第6章 製品タイプ別

• EPアブレーションカテーテル
• EP診断カテーテル
• EPラボ機器
• アクセスデバイス
• その他

第7章 適応症別

• 心房細動（AF）
• 心房粗動
• 房室結節リエントリー性頻拍（AVNRT）
• 心室頻拍
• その他

第8章 エンドユーザー別

• 病院
• 外来手術センター（ASC）
• 専門クリニック
• 診断センター

第9章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋
• 中東・アフリカ

第10章 競合情勢

• 競合シナリオ
• 市況・シェア分析
• M&A分析

第11章 企業プロファイル

• Biosense Webster, Inc.（Johnson & Johnson）
  • 会社概要
  • 製品ポートフォリオと概要
  • 財務概要
  • 主な発展
• Abbott Laboratories
• Medtronic plc
• Boston Scientific Corporation
• Siemens Healthineers AG
• GE HealthCare
• Philips Healthcare
• Acutus Medical, Inc.
• Stereotaxis, Inc.
• MicroPort Scientific Corporation

第12章 付録

The global electrophysiology market reached US$ 8.24 billion in 2023 and is expected to reach US$ 23.0 billion by 2033, growing at a CAGR of 10.7% during the forecast period 2025-2033.

An electrophysiology is a cardiology field that analyzes the electrical activity in the heart to diagnose and treat abnormal heart rhythms. Healthcare providers use cardiac catheters and computers to create electrocardiogram (EKG) tracings and electrical measurements from inside the heart. The study helps identify issues with heartbeat signals, which typically follow a consistent route. The sensors placed inside the heart provide more information than external electrodes.

Market Dynamics: Drivers & Restraints

Rise in the Technological Advancements

The global electrophysiology market is growing due to technological advancements in diagnostic and therapeutic tools. Advanced mapping systems, catheter designs, and robotic-assisted procedures are improving cardiac arrhythmia diagnosis and treatment efficiency. Artificial intelligence and machine learning are revolutionizing data analysis, enabling personalized treatment plans and reducing procedural risks. The development of wireless and miniaturized devices and real-time monitoring capabilities is expanding electrophysiology Indications, improving patient outcomes and addressing the growing demand for minimally invasive procedures.

For instance, in January 2024, GE HealthCare has introduced the Prucka 3 with CardioLab EP Recording system, a cutting-edge electrophysiology tool, to aid clinicians in diagnosing and treating cardiac arrhythmias. This system, built on over twenty years of electrophysiology expertise, offers a comprehensive ecosystem of mapping technologies for accurate, efficient, and advanced analytics in cardiac arrhythmia diagnosis and treatment.

Shortage of Skilled Professionals

The global electrophysiology market faces a significant shortage of skilled professionals due to the complexity of procedures requiring specialized expertise. This, especially in developing regions, can hinder the widespread adoption of advanced technologies like catheter-based ablation and electrophysiology mapping systems. This shortage results in increased pressure on existing professionals, longer wait times, and potentially compromised patient outcomes. Addressing this skill gap is crucial for market growth and efficient use of advanced technologies.

Segment Analysis

The global electrophysiology market is segmented based on product type, indication, end user and region.

Product Type:

EP Ablation Catheters segment is expected to dominate the Electrophysiology market share

The EP ablation catheters segment holds a major portion of the electrophysiology market share and is expected to continue to hold a significant portion of the electrophysiology market share during the forecast period.

EP ablation catheters are essential in the global electrophysiology market for treating arrhythmias like atrial fibrillation and ventricular tachycardia. They deliver radiofrequency energy or cryotherapy to specific heart areas, disrupting abnormal electrical pathways. Their growth is driven by the rise in cardiovascular diseases, advancements in catheter technology, and the need for more efficient, safer, and less invasive treatments. Innovations like improved designs, navigation systems, and real-time imaging have made EP ablation catheters a cornerstone in electrophysiology, improving patient outcomes and market expansion.

For instance, in October 2024, Medtronic has received FDA approval for an early feasibility study to evaluate the Affera Mapping and Ablation System with Sphere-9 Catheter for treating sustained ventricular tachycardia (VT), a potentially life-threatening abnormal heart rhythm affecting the lower chamber of the heart. The system is an all-in-one, dual-energy ablation and high-density mapping catheter used in cardiac electrophysiology ablation procedures.

Indication:

Atrial Fibrillation (AF) segment is the fastest-growing segment in Electrophysiology market share

The atrial fibrillation (AF) segment is the fastest-growing segment in the electrophysiology market share and is expected to hold the market share over the forecast period.

Atrial fibrillation (AF) is a rapidly growing cardiovascular condition that demands precise diagnosis and management through electrophysiology procedures like catheter ablation. The increasing prevalence of AF due to aging populations and risk factors like hypertension and diabetes has driven demand for advanced electrophysiology technologies and treatments. The market growth is accelerated by the need for innovative diagnostic tools, ablation catheters, and advanced mapping systems. Improved treatment options like cryoablation and radiofrequency ablation are providing better outcomes for AF patients, making it a central focus within the electrophysiology sector.

For instance, in November 2024, Johnson & Johnson MedTech has received FDA approval for the VARIPULSE Platform, a device designed to treat drug refractory paroxysmal Atrial Fibrillation (AFib). The VARIPULSE Platform combines PFA therapy and advanced mapping with the CARTO 3 System, a leading 3D electroanatomical cardiac mapping system. It is designed for full integration with CARTO.

Geographical Analysis

North America is expected to hold a significant position in the Electrophysiology market share

North America holds a substantial position in the electrophysiology market and is expected to hold most of the market share due to advanced healthcare infrastructure, acquisitions, high healthcare spending, and emphasis on technological innovations. The region's medical device industry invests heavily in research and development for cutting-edge electrophysiology technologies. The increasing prevalence of cardiovascular diseases and aging population drive demand for electrophysiology procedures. North America's skilled healthcare professionals and favourable reimbursement policies further fuel the market's growth.

For instance, in November 2024, Boston Scientific has acquired Cortex, a pioneer in pulsed field ablation (PFA) technology, to enhance its capabilities in electrophysiology and cardiac care solutions. This acquisition is a significant step for Boston Scientific, which aims to refine treatments for heart rhythm disorders, potentially improving patient outcomes.

Moreover, in May 2024, Biosense Webster, part of Johnson & Johnson MedTech, has launched CARTO 3 System Version 8, the latest version of its three-dimensional heart mapping system for cardiac ablation procedures. The software includes new modules like the CARTO ELEVATE Module and CARTOSOUND FAM Module, enhancing efficiency, reproducibility, and accuracy for electrophysiologists treating patients with atrial fibrillation and other arrhythmias.

Europe is growing at the fastest pace in the Electrophysiology market

Europe holds the fastest pace in the electrophysiology market and is expected to hold most of the market share due to ageing population and increasing heart disease incidence. The demand for minimally invasive procedures is increasing due to their effectiveness in treating arrhythmias and other heart conditions. Advanced diagnostic technologies, like catheter-based ablation and mapping systems, are gaining popularity in advanced countries like Germany, France, and the UK. Collaboration between healthcare providers and manufacturers, regulatory support, and a focus on personalized medicine contribute to the market's growth.

For instance, in July 2024, Volta Medical has announced a Joint Development Agreement with GE HealthCare to integrate its Volta AF-Xplorer AI solution with GE HealthCare's Prucka 3 and CardioLab EP Recording system. The goal is to improve performance and streamline workflows for electrophysiologists during catheter ablation procedures for treating atrial fibrillation (AFib), enhancing their efficiency.

Competitive Landscape

The major global players in the Electrophysiology market include Biosense Webster, Inc. (Johnson & Johnson), Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Siemens Healthineers AG, GE HealthCare, Philips Healthcare, Acutus Medical, Inc, Stereotaxis, Inc, MicroPort Scientific Corporation and among others.

Key Developments

• In December 2024, Havasu Regional Medical Center, a LifePoint hospital, has launched an electrophysiology program to diagnose and treat heart arrhythmia. The program aims to improve patient outcomes and reduce the stress and financial burden associated with traveling for care. Arrhythmias, which occur when the heart beats too slowly, too fast, or irregularly, affect around 9.5 million people in the US. AFib, the most common type, has a five-fold higher stroke risk in those with AFib compared to those without it.
• In October 2024, KIMSHEALTH Trivandrum has inaugurated a state-of-the-art Electrophysiology Lab with advanced 3D mapping technology, inaugurated by Dr. S Somanath, Chairman of ISRO.

Emerging Players

The emerging players in the electrophysiology market include CathRx, Grid Medical, Acutus Medical, CardioFocus, Inc and among others.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global electrophysiology market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Component & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product Type
• 3.2. Snippet by Indication
• 3.3. Snippet by End User
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Rise in the Technological Advancements
  • 4.1.2. Restraints
    • 4.1.2.1. Shortage of Skilled Professionals
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis

6. By Product Type

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 6.1.2. Market Attractiveness Index, By Product Type
• 6.2. EP Ablation Catheters *
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. EP Diagnostic Catheters
• 6.4. EP Laboratory Devices
• 6.5. Access Devices
• 6.6. Others

7. By Indication

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
  • 7.1.2. Market Attractiveness Index, By Indication
• 7.2. Atrial Fibrillation (AF)*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Atrial Flutter
• 7.4. Atrioventricular Nodal Reentry Tachycardia (AVNRT)
• 7.5. Ventricular Tachycardia
• 7.6. Others

8. By End User

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 8.1.2. Market Attractiveness Index, By End User
• 8.2. Hospitals*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Ambulatory Surgical Centers (ASCs)
• 8.4. Specialized Clinics
• 8.5. Diagnostic Centers

9. By Region

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 9.1.2. Market Attractiveness Index, By Region
• 9.2. North America
  • 9.2.1. Introduction
  • 9.2.2. Key Region-Specific Dynamics
  • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
  • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.2.6.1. U.S.
    • 9.2.6.2. Canada
    • 9.2.6.3. Mexico
• 9.3. Europe
  • 9.3.1. Introduction
  • 9.3.2. Key Region-Specific Dynamics
  • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
  • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.3.6.1. Germany
    • 9.3.6.2. U.K.
    • 9.3.6.3. France
    • 9.3.6.4. Spain
    • 9.3.6.5. Italy
    • 9.3.6.6. Rest of Europe
• 9.4. South America
  • 9.4.1. Introduction
  • 9.4.2. Key Region-Specific Dynamics
  • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
  • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.4.6.1. Brazil
    • 9.4.6.2. Argentina
    • 9.4.6.3. Rest of South America
• 9.5. Asia-Pacific
  • 9.5.1. Introduction
  • 9.5.2. Key Region-Specific Dynamics
  • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
  • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.5.6.1. China
    • 9.5.6.2. India
    • 9.5.6.3. Japan
    • 9.5.6.4. South Korea
    • 9.5.6.5. Rest of Asia-Pacific
• 9.6. Middle East and Africa
  • 9.6.1. Introduction
  • 9.6.2. Key Region-Specific Dynamics
  • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
  • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

• 10.1. Competitive Scenario
• 10.2. Market Positioning/Share Analysis
• 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

• 11.1. Biosense Webster, Inc. (Johnson & Johnson)*
  • 11.1.1. Company Overview
  • 11.1.2. Product Portfolio and Description
  • 11.1.3. Financial Overview
  • 11.1.4. Key Developments
• 11.2. Abbott Laboratories
• 11.3. Medtronic plc
• 11.4. Boston Scientific Corporation
• 11.5. Siemens Healthineers AG
• 11.6. GE HealthCare
• 11.7. Philips Healthcare
• 11.8. Acutus Medical, Inc.
• 11.9. Stereotaxis, Inc.
• 11.10. MicroPort Scientific Corporation

LIST NOT EXHAUSTIVE

12. Appendix

• 12.1 About Us and Services
• 12.2 Contact Us